(9/10) #JACC #Tweetorial: Unlike T1MI, a uniform pathophysiological entity for which management guidelines exist, for T2MI, evidence is lacking. Recognizing the heterogeneous mechanisms leading to T2MI, a phenotype-specific approach is endorsed. https://t.
RT @JACCJournals: (7/10) #JACC #Tweetorial: 1st steps for T2MI diagnosis include careful H&P, serial #troponin & 12-lead #ECG. When signs a…
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(8/10) #JACC #Tweetorial: What is the prognosis of T2MI? Patients w/ T2MI have ⬆ risk for CV mortality & MACE, w/ similar or higher all-cause mortality than T1MI. 24-43% die from CV causes, suggesting opportunities to improve outcomes during follow up.
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(7/10) #JACC #Tweetorial: 1st steps for T2MI diagnosis include careful H&P, serial #troponin & 12-lead #ECG. When signs are unclear, emphasis should be placed on finding objective evidence of myocardial ischemia (ex. cardiac imaging). https://t.co/
(6/10) #JACC #Tweetorial: In the absence of myocardial ischemia, numerous conditions can lead to #troponin ⬆ including direct drug-toxicity & cardioversion. Conceptually, myocardial injury (acute or chronic) = isolated troponin ⬆ w/o myocardial ischemi
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(5/10) #JACC #Tweetorial: T2MI diagnosis requires 1️⃣: ⬆ or ⬇ cTn with ≥ value > 99th percentile 2️⃣: Clinical evidence of myocardial ischemia in the absence of acute atherothrombosis. https://t.co/MqCPzXziHR #cvAMI https://t.co/ErP46lVsfc
(4/10) #JACC #Tweetorial: Are all T2MIs secondary to other illness or processes? Some are present due to coronary etiologies, such as spasm, embolism, spontaneous coronary artery dissection and endothelial dysfunction, or w/ aortic dissection. https://t.co
RT @JACCJournals: (3/10) #JACC #Tweetorial: How T2MI manifests depends on the pathobiology & clinical context, w/ T2MIs less likely to have…
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(3/10) #JACC #Tweetorial: How T2MI manifests depends on the pathobiology & clinical context, w/ T2MIs less likely to have chest pain, imaging/#ECG abnormalities & ⬇ cardiac troponin concentrations compared to T1MI. Many T2MIs are driven by other il
RT @JACCJournals: (2/10) #JACC #Tweetorial: Frequency of T2MI varies widely due to differences in populations, comorbidities, adjudication…
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(2/10) #JACC #Tweetorial: Frequency of T2MI varies widely due to differences in populations, comorbidities, adjudication processes, & cTN assays, w/ a major challenge being the absence of uniform definitions that can be useful w/ high reproducibility.
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
RT @JACCJournals: (1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absenc…
(1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absence of acute atherothrombosis. It can occur in pts w/ normal coronaries and in obstructive/non-obstructive stable #cvCAD. https://t.co/Mq
RT @yadersandoval: In press @JACCJournals: Type 2 MI: https://t.co/q1OQyNSG4h → frequently encountered heterogeneous entity requiring clini…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @drsaavedra: Type 2 Myocardial Infarction @JACCJournals Review Topic of the Week https://t.co/BZ5mSFjbWM https://t.co/RCgUzscAJJ
5/5 ⚡️ Bottomline ⚡️ ✅ “NSTEMI Type 2” or “NSTEMI Type 1” terminology doesn’t exist ✅ NSTEMI = Type 1 MI ✅ Type 2 MI = Type 2 MI https://t.co/Qm5LVRBjiv All cardiologists should read these 2 papers 👇 https://t.co/nqJf8bzUht https://t.co/nReAIyXDVs
4/5 Based on 2018 Universal Definition of MI, @yadersandoval paper & current ICD10, Type 2 MI is NOT classified based on STE & CANNOT be called NSTEMI (or STEMI even though STE may happen in 3–24% of cases, e.g. coronary embolism) https://t.co/tJAy
Type 2 Myocardial Infarction: JACC Review Topic of the Week https://t.co/oQoYa0MrRI
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @CoronaryDoc: All cardiologists should read these 2 @JACCJournals papers & save these 2 slides on their phone ✅ Universal Definition of…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
Excellent infographic summarising the issues in myocardial infarction
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @ATRIUMRx: Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
Check out this comprehensive review for details regarding pathophysiology, diagnosis, and management of patients with type 2 MI #FOAMed
https://t.co/82Yn8qkGea do you know it ?
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
RT @JACCJournals: Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yaders…
Are you up to date on identifying, diagnosing and treating Type 2 MI? https://t.co/lQqqcpe8Zn #JACC @MayoClinicCV @yadersandoval https://t.co/yRedzucWKc
RT @smithECGBlog: Another great article from Yader https://t.co/0kF64oRRW9
RT @sccccardio: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. 🖇https://t.co/FPvRQrX6f1 #cvMI @MayoCli…
RT @JACCJournals: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. https://t.co/u96eujCvva #cvMI @MayoClin…
RT @JACCJournals: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. https://t.co/u96eujCvva #cvMI @MayoClin…
RT @CoronaryDoc: All cardiologists should read these 2 @JACCJournals papers & save these 2 slides on their phone ✅ Universal Definition of…
RT @shinrihataro: 4つのタイプの心筋梗塞という考え方があるんですね。そしてこのフローチャートわかりやすい。 https://t.co/J6UrOt5Ckd
4つのタイプの心筋梗塞という考え方があるんですね。そしてこのフローチャートわかりやすい。
RT @CoronaryDoc: All cardiologists should read these 2 @JACCJournals papers & save these 2 slides on their phone ✅ Universal Definition of…
RT @yadersandoval: In press @JACCJournals: Type 2 MI: https://t.co/q1OQyNSG4h → frequently encountered heterogeneous entity requiring clini…
RT @yadersandoval: In press @JACCJournals: Type 2 MI: https://t.co/q1OQyNSG4h → frequently encountered heterogeneous entity requiring clini…
Type 2 Myocardial Infarction https://t.co/6BG85tabbd
RT @JACCJournals: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. https://t.co/u96eujCvva #cvMI @MayoClin…
RT @JACCJournals: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. https://t.co/u96eujCvva #cvMI @MayoClin…
RT @JACCJournals: Are you up to speed on Type 2 MI? Learn with this #JACC Review Topic of the Week. https://t.co/u96eujCvva #cvMI @MayoClin…
RT @CoronaryDoc: All cardiologists should read these 2 @JACCJournals papers & save these 2 slides on their phone ✅ Universal Definition of…